Group Wellness Interventions for Neurologic Conditions
Trial Summary
What is the purpose of this trial?
Approximately 5.3 million people live with a long-term disability resulting from a traumatic brain injury (TBI) and between 5-8% of those older than 60 suffer from Alzheimer's disease or other forms of dementia (ADRD). Consequences of these conditions can result in dramatic and persistent changes in functioning, impacting not only the patients, but also loved ones who become informal support persons. Many existing services help the family in the moment, but do not address long-term wellness. Thus, the purpose of this research study is to compare the effect of two different types of group wellness treatments for individuals with chronic mild TBI, moderate to severe TBI, and ADRD and their support persons.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Group Wellness Interventions for Neurologic Conditions?
Research shows that various evidence-based interventions, such as group therapy and education, can improve outcomes and quality of life for patients with neurological conditions. These interventions help with symptom management, enhance motor and cognitive functions, and support vocational reintegration.12345
Is the Group Wellness Intervention for Neurologic Conditions safe for humans?
How is the Group Wellness Interventions treatment different from other treatments for neurological conditions?
The Group Wellness Interventions treatment is unique because it focuses on group classes that combine social support, individualized programming, and experiential learning, which are not typically emphasized in standard neurological treatments. This approach aims to improve physical and social well-being, which can be particularly beneficial for managing chronic neurological conditions.4781112
Eligibility Criteria
This trial is for adults aged 18-64 with mild or severe TBI at least a few months post-injury, and those 65+ with ADRD at least one year post-diagnosis. Participants must speak English fluently and have a support person willing to join the study. Excluded are individuals with significant neurological history other than their condition, uncontrolled seizures, recent psychiatric hospitalization, or substance abuse affecting daily functions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive one of two different online group wellness treatments designed to improve self-efficacy and quality of life
Follow-up
Participants are monitored for changes in self-efficacy and life satisfaction after treatment
Treatment Details
Interventions
- Group Wellness Class 1
- Group Wellness Class 2
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kessler Foundation
Lead Sponsor
Rehabilitation Hospital of Indiana
Collaborator
University of California, San Diego
Collaborator
University of Michigan
Collaborator
Franciscan Health
Collaborator